Remove 2020 Remove Capital Remove San Diego Remove Venture Capital
article thumbnail

Resilience Gets $164M From Government Of Canada

socalTECH

San Diego-based National Resilience, a new manufacturing and technology company focused on making sure countries can manufacture their own vaccines and other threapeutics, says it has received $163.8M National Resilience has raised more than $800M in venture capital funding, with funding from ARCH Venture Partners, 8VC, GV, and NEA.

High Tech 113
article thumbnail

Tech Coast Angels Los Angeles Launches New Members Only Fund

socalTECH

According to the group's Los Angeles chapter, the Tech Coast Angeles-Los Angeles (TCA-LA), it is launching a new annual fund which will provide "new and diverse opportunities for investors and an additional source of startup capital for entrepreneurs."

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Flagship Adds $1.1B for New Meds, More AI, & “Health Security”

Xconomy

Flagship Pioneering founder and CEO Noubar Afeyan didn’t know a global pandemic was in the cards for 2020 when he and his team laid out three new thematic areas of focus for the company last fall. On Thursday the Cambridge, MA-based venture capital firm, best known for starting and spinning out biotechs, announced it had added $1.1

article thumbnail

Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More

Xconomy

At the start of 2020 thousands of biotechies anticipated spending the second week of June in San Diego, hobnobbing at the annual conference hosted by the Biotechnology Innovation Organization. There, topics once as unanticipated as the remote nature of the meeting shared top billing: COVID-19 and racism.

San Diego 121
article thumbnail

Abodu raises $20M to build prefabricated backyard homes

TechCrunch LA

Previous backer Initialized Capital also participated in the financing, along with Redfin CEO Glenn Kelman, former Stockton, California Mayor Michael Tubbs, GGV investor Hans Tung and Paradox Capital’s Kyle Tibbitts. Next, Abodu is eyeing the San Diego market.

article thumbnail

Life Sciences IPOs Target Collective Raise of More Than $600M This Week

Xconomy

By month’s end, five more are anticipated to join the class of 2020 initial public offerings—and four of those are in life sciences, according to IPO research firm Renaissance Capital. So far this year four privately held companies have made the transition to trading on the public markets.

article thumbnail

Biopharma Execs Remain Optimistic Despite Political Headwinds

Xconomy

Nevertheless, senior figures remain optimistic about the industry’s prospects in 2020. Nearly half of respondents believe that political and policy uncertainty present the greatest risks in 2020, with the latest Brexit developments and approaching UK and US elections seeing concerns around political volatility growing.

Pricing 78